Phreesia’s (NYSE:PHR) quiet period is set to expire on Tuesday, August 27th. Phreesia had issued 9,288,194 shares in its public offering on July 18th. The total size of the offering was $167,187,492 based on an initial share price of $18.00. During Phreesia’s quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

A number of equities analysts have recently weighed in on the company. JPMorgan Chase & Co. assumed coverage on Phreesia in a research note on Tuesday, August 13th. They issued an “overweight” rating and a $33.00 target price on the stock. Wells Fargo & Co assumed coverage on Phreesia in a research note on Monday, August 12th. They issued an “outperform” rating and a $23.00 target price on the stock. William Blair assumed coverage on Phreesia in a research note on Monday, August 12th. They issued an “outperform” rating on the stock. Piper Jaffray Companies assumed coverage on Phreesia in a research note on Monday, August 12th. They issued an “overweight” rating and a $33.00 target price on the stock. Finally, Chardan Capital assumed coverage on Phreesia in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $33.00 target price on the stock. Five analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus price target of $30.50.

Shares of NYSE PHR opened at $26.31 on Monday. Phreesia has a twelve month low of $23.00 and a twelve month high of $29.38.

In other news, major shareholder Ii L.P. Chv sold 335,767 shares of the company’s stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total value of $6,043,806.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Scott Perricelli sold 743,388 shares of the company’s stock in a transaction on Monday, July 22nd. The stock was sold at an average price of $18.00, for a total transaction of $13,380,984.00. The disclosure for this sale can be found here.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

Featured Story: Google Finance Portfolio Tips and Tricks

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.